Table 3.

Recent novel peptides showing anti-atherosclerotic or anti-inflammatory effects

Year	Group	Peptide	Sequence or Component	Ref.
2017	Zhou	Rice α-globulin peptide	GEQQQQPGM	[104]
2018	Tang	apoA-I mimetic peptide	ELK-2A2K2E	[105]
2018	Karas	Schistocerca gragaria peptide	FDPFPK	[106]
2018	Watanabe	Nicotiana tabacum peptide	Osmotin	[107]
2018	Wu	Spent hen muscle proteins	FLWGKSY	[108]
2019	Lagerstedt	apoA-I mimetic peptide	RG54, 54 amino acid sequence	[109]
2019	Zhou	Rice α-globulin peptides	YYGGEGSSSEQG; SESEM	[110]
2019	Hadri	Thioredoxin-mimetic peptide	Ac-CPC-amide	[111]
2019	Salifu	F11 receptor derived peptide	2HN-(dK)-SVT-(dR)-EDTGTYTC-CONH2	[112]
2019	Miura	apoA-I mimetic peptide	ALEHLFTLYEKALKALEDLLKKLLD-A	[113]
2020	Ni	apoA-I mimetic peptide	FLEKLKELLEHLKELLTKLL	[114]
2020	Ji	Leech peptide	EAGSAKELEGDPVAG	[115]
2020	Sanchez-Quesada	apoJ mimetic peptide	Ac-LVGRQLEEFL-NH2	[116]

Notes and Abbreviations: apoA-I: apolipoprotein A1; F11 receptor: Junctional adhesion molecule A encoded by the F11R gene; apoJ: apolipoprotein J.